Pathogenic

Aberrant Labs · 2026 · $9.99 · Action · deal grade C

Measured on 2026-10-02 22:27 UTC, 3 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $62.8k to $94.1k per month
• Opportunity: $78.4k per month at x1.00 dormancy
• Estimated lifetime owners: 174.0k
• 93% positive across 4491 reviews · 936.6 reviews/month

Why it's flagged

• Developer active, last post 0 months ago
• Last discounted 0 months ago, 3 sales in the last 12 months

This case as Markdown · Estimates carry ±30-50% error per title.